Tesofensine is not FDA approved and its long-term safety profile is not fully characterized
Inclusion in the trial was based on BMI, not waist-to-height ratio, Borlaug noted during a panel discussion following his presentation
clinicians should consult trial protocols, seek endocrinology input, and document clinical rationale with informed consent
Everything is determined clinically not by an algorithm
When you follow our dietary program while using Semaglutide or Tirzepatide, youre giving your body the support it needs to restore metabolic balance, improve insulin sensitivity, and maintain long-term results
File the internal appeal within the plan deadline, typically 60 days, then request an external independent medical review if it fails